ClinicalTrials.Veeva

Menu

Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer (CLIPP)

University of Arizona logo

University of Arizona

Status

Completed

Conditions

Prostate Cancer

Treatments

Behavioral: CLIPP

Study type

Interventional

Funder types

Other

Identifiers

NCT04000464
1806697620

Details and patient eligibility

About

This study is an investigator initiated clinical study. A prospective, single arm unblinded, open label study will be carried out to determine the feasibility of recruitment, retention and adherence of 30 prostate cancer survivors who have been on androgen deprivation therapy within the last 5 years for a lifestyle modification intervention.

Full description

Introduction

  • Androgen deprivation therapy (ADT) has been demonstrated to improve disease free and over-all survival in men with prostate cancer (PCa).
  • ADT for PCa is associated with adverse cardio-metabolic effects such as reduced libido, hot flashes, metabolic syndrome, diabetes, myocardial infarction and stroke. This reduces quality of life (QoL) and potentially affects mortality.
  • There is paucity of data regarding comprehensive lifestyle interventions in men on ADT for Pca. Existing studies used non-standardized interventions or lack data on metabolic risk factors.
  • CLIPP is designed to address these gaps by using an intervention modelled after the Diabetes Prevention Program (DPP), a standardized multi-component intervention with demonstrated effectiveness in reducing diabetes risk factors that has been successfully adapted for multiple disease types including breast cancer.

Intervention:

  • 24 Weeks
  • Health Coaching Weekly
  • Serum & Urine Baseline, Week 12 and Week 24
  • Anthropometric Measures
  • Questionnaires
  • Dual-energy X-ray absorptiometry (DXA) at Baseline and Week 24

Enrollment

31 patients

Sex

Male

Ages

40 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with prostate cancer Stage I, II or IV
  • On androgen deprivation therapy with last 5 years
  • Willing to participate in a lifestyle modification program
  • Willing to modify diet and eating practices
  • Willing to participate in blood collection, urine collection and measurements
  • Minimum of 30 days since participating in another study/trial
  • English speaking
  • 40 years of age or older

Exclusion criteria

  • Currently participating in another study or trial
  • Currently in hospice
  • Inability to walk two city blocks
  • Inability to comprehend informed consent or procedural requirements
  • Digestive Diseases (IBD, Diverticulitis, etc) that might prevent him from increasing fruit and vegetable intake

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

31 participants in 1 patient group

Single Arm
Experimental group
Description:
24 Week Lifestyle Modification intervention
Treatment:
Behavioral: CLIPP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems